Skip to main content
LFMD
NASDAQ Life Sciences

LifeMD Misses Q2 Revenue, Slashes 2026 Guidance on GLP-1 Shift

Tom Rudovsky · Reported by Reuters
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$3.4
Mkt Cap
$177.974M
52W Low
$2.56
52W High
$12.72
52W Position info
33% above low
Off High info
73% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

LFMD sits 33% above its 52-week low of $2.56 on elevated volume (1.9× avg).

Summary

LifeMD's Q2 revenue fell short of estimates at $47.3M, and adjusted EBITDA loss widened to -$3.5M, missing consensus by a wide margin. The company blamed a transition from compounded to branded GLP-1 therapies, which reduced upfront revenue. Gross margin improved to 89%, but the top-line miss and guidance cut overshadow it. Full-year 2026 revenue guidance was slashed to $205.5M-$212.5M from $220M-$230M, signaling a slower recovery. This follows a Q1 net loss and debt covenant breach, adding to financial stability concerns. Active subscribers grew 20% YoY, but the near-term outlook remains pressured. Q3 guidance of $48M-$51M revenue and adjusted EBITDA between -$1M and +$2M will be the next checkpoint.

At the time of this announcement, LFMD was trading at $3.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $178M. The 52-week trading range was $2.56 to $12.72. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LFMD - Latest Insights

LFMD
Nov 12, 2026, 4:58 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.61
Real-time Price: $1.60 info
Change: -$0.010 (-0.62%) info
Market Cap: $77.092M info
LFMD
Nov 12, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $1.60 info
Change: +$0.110 (+7%) info
Market Cap: $77.092M info
LFMD
Nov 12, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.54
Real-time Price: $1.60 info
Change: +$0.0599 (+4%) info
Market Cap: $77.092M info
LFMD
Nov 09, 2026, 9:39 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $1.98
Real-time Price: $1.60 info
Change: -$0.380 (-19%) info
Market Cap: $77.092M info
LFMD
Sep 15, 2026, 10:18 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.30
Real-time Price: $1.60 info
Change: -$1.69 (-51%) info
Market Cap: $77.092M info